| Basics |
Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals Inc is engaged in developing and commercializing differentiated therapies to patients living with chronic skin conditions. It develops solutions in to treat skin conditions, such as acne, atopic dermatitis, and scarring.
|
| IPO Date: |
February 1, 2007 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$5.51M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.14 | 3.63%
|
| Avg Daily Range (30 D): |
$0.11 | 3.17%
|
| Avg Daily Range (90 D): |
$0.12 | 4.22%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.59M |
| Avg Daily Volume (30 D): |
.12M |
| Avg Daily Volume (90 D): |
1.58M |
| Trade Size |
| Avg Trade Size (Sh.): |
273 |
| Avg Trade Size (Sh.) (30 D): |
203 |
| Avg Trade Size (Sh.) (90 D): |
154 |
| Institutional Trades |
| Total Inst.Trades: |
15 |
| Avg Inst. Trade: |
$.97M |
| Avg Inst. Trade (30 D): |
$M |
| Avg Inst. Trade (90 D): |
$M |
| Avg Inst. Trade Volume: |
M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
K |
|
|
| Financials |
| |
TTM |
Q2 2025 |
Q1 2025 |
|
Basic EPS
|
$-.63
|
$-.59
|
$-.07
|
|
Diluted EPS
|
$-.63
|
$-.59
|
$-.07
|
|
Revenue
|
$ 3.56M
|
$ 3.58M
|
$ 3.39M
|
|
Gross Profit
|
$ 1.27M
|
$ 1.36M
|
$ 1.31M
|
|
Net Income / Loss
|
$ -.93M
|
$ -.61M
|
$ -1.14M
|
|
Operating Income / Loss
|
$ -1.03M
|
$ -.85M
|
$ -1.17M
|
|
Cost of Revenue
|
$ 2.29M
|
$ 2.22M
|
$ 2.09M
|
|
Net Cash Flow
|
$ 1.16M
|
$ 1.49M
|
$ -.54M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Aug 30, 2024:
1:20
|
|
Jun 20, 2019:
1:9
|
|
Jun 27, 2016:
1:5
|
|
Apr 01, 2013:
1:7
|
|
|
|
